The regression of endometriosis with glycosylated flavonoids isolated from Melilotus officinalis (L.) Pall. in an endometriosis rat model

İlhan M., Ali Z., Khan I. A., TAŞTAN H., AKKOL E.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, cilt.59, sa.2, ss.211-219, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 59 Sayı: 2
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.tjog.2020.01.008
  • Dergi Adı: TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Sayfa Sayıları: ss.211-219
  • Anahtar Kelimeler: Endometriosis, Glycosylated flavonoids, Fabaceae, Melilotus officinalis, Rat, ENDOTHELIAL GROWTH-FACTOR, PERITONEAL-FLUID, IN-VITRO, VEGF EXPRESSION, ANGIOGENESIS, CANCER, CELLS, INHIBITION, KAEMPFEROL, MODULATION
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective: Melilotus officinalis (L.) Pall. is commonly used for treating bronchitis, painful menstruation, hemorrhoids, kidney stones, ulcers of the eyes, earache, and hardening and swelling of uterus. The European Medicines Agency reported the use of M. officinalis orally against stomach ache, gastric ulcer, and disorders of the liver and uterus in folk medicine. The present study aimed to appraise the activity of M. (L.) Pall. aerial parts in endometriosis rat model.